EVM
NBP

Eaton Vance Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Eaton Vance Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-240
Closed -$11K – 2250
2021
Q4 		$11K Sell
240
-500
-68% -$30K ﹤0.01% 2517
2021
Q3 		$54K Buy
+740
New +$53.5K ﹤0.01% 1510

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eaton Vance Management's NBP Position: Q1 2022 in Review

Eaton Vance Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 240 shares — an estimated $11K sold.

Eaton Vance Management first reported a position in NBP in Q3 2021 and held it in 2 quarters. The position peaked at $54K in Q3 2021. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

  • Eaton Vance Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 240 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $11K.
  • Eaton Vance Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 2 quarters.
  • Eaton Vance Management's NovaBridge Biosciences American Depositary Shares position peaked at $54K in Q3 2021.
  • 120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.